Web Version

Accelerate drug discovery and new indication research

Identifying novel and robust chemical starting points remains one of the biggest challenges in drug discovery today. Small molecule modulators that bind to target proteins and regulate their biological activity have many advantages. In addition to their inherent stability, cell permeability and bioavailability, they can be easily manipulated and can be applied to a variety of cell or animal experiments.
A large collection of bioactive compounds, including FDA-approved drugs and promising SARS-CoV-2 antiviral agents, is offered.

20% OFF* TargetMol Bioactive Compounds

  • Validated biological and pharmacological activity
  • Many compounds FDA-approved
  • Structurally diverse and cell-permeable
  • NMR- and HPLC-verified to ensure high purity
  • Short delivery time
  • Detailed specifications

*Expires 15 April 2021

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com